Status:
COMPLETED
The Effect Of Antenatal Corticosteroids On Early And Late Perinatal Outcomes
Lead Sponsor:
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Conditions:
Preterm Pregnancy
Antenatal Corticosteroid
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
In this study, the investigators aims to evaluate whether antenatal corticosteroid administration to women likely to give birth in the late preterm period will reduce early and late neonatal complicat...
Detailed Description
This study is a single-center prospective case-control study investigating the effect of antenatal corticosteroids administered in the late preterm period on early and late perinatal outcomes. 459 pat...
Eligibility Criteria
Inclusion
- All pregnant women who had normal vaginal delivery, cesarean section or operative delivery between 34-37 weeks
- Singleton pregnancies resulting in a live birth
Exclusion
- Twin pregnancies
- All births before 34 weeks or after 37 weeks
- Pregnant women with intrauterine ex fetus
- Fetuses with major congenital and chromosomal abnormalities
- Pregnant women who administrated antenatal corticosteroids for any reason before 34 weeks
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
459 Patients enrolled
Trial Details
Trial ID
NCT06164080
Start Date
June 1 2021
End Date
October 1 2022
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nefise Nazlı YENIGUL
Bursa, Turkey (Türkiye), 16110